FAP-Targeted LTβR Agonist Drives HEV Differentiation and Immune Niche Formation for Improved Immunotherapy Response in Solid Tumors
Year: 2026
Type: article
Source: Clinical Cancer Research
Authors: Roberta Bianchi, Leo Kunz, Ralf J. Hosse, Michelle Brydon, Ana Amorim, Petra C. Schwalie, Dario Speziale, Ahmet Varol, Birte Appelt, Elzbieta Drozdowicz, Marine le Clech, Alberto Valdeolivas, Nadine Kumpesa, Kerstin Hahn, Marion Richardson, Nicolas Giroud, Benedek Pesti, Christian Gassner, Reiner Wimmer, Louisa Henniger, Remi Villenave, Christophe Boetsch, Ulrike Hopfer, Juliana Bessa, Christine Trumpfheller, Meher Majety, Pablo Umaña
Institution: Roche (Switzerland)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7155068500